Cartesian Therapeutics, Inc. (RNAC)

NGM – Real vaqt narxi. Valyuta: USD

8.79

+0.20 (2.39%)

Bozor ochiq: Aug 12, 2026, 3:04 PM EDT

8.59

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to four new employees consisting of options to purchase an aggregate of 115,250 shares of the Company's common stock with effective grant dates of August 3, 2026 and August 6, 2026.

06.08.2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) continues to advance; data expected in 1Q27, biologics license application (BLA) filing planned for mid-2027

Videolar

No Data

There is no data to display

Press-relizlar

07.08.2026

Cartesian Therapeutics Announces New Employment Inducement Grants

06.08.2026

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis (MG) continues to advance; data expected in 1Q27, biologics license application (BLA) filing planned for mid-2027

Cartesian Therapeutics, Inc. (RNAC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Search stocks

Cartesian Therapeutics, Inc. (RNAC)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Cartesian Therapeutics, Inc. (RNAC)

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videolar

No Data

Press-relizlar

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update